Literature DB >> 19344907

Determination of antihyperglycemic drugs in nanomolar concentration levels by micellar electrokinetic chromatography with non-ionic surfactant.

Vítezslav Maier1, Joanna Znaleziona, David Jirovský, Jana Skopalová, Jan Petr, Juraj Sevcík.   

Abstract

A method for the separation of six selected antihyperglycemic (antidiabetic) drugs (tolbutamide, gliclazide, glimepiride, glibenclamide, repaglinide, and glipizide) was developed with use of micellar electrokinetic chromatography. Two non-ionic poly(ethylene glycol)-based surfactants Genapol X-080 and Triton X-114 (reduced) were studied as neutral pseudostationary phases. High alkaline pH 10.0 was used to obtain negative charges of separated antidiabetic drugs and non-ionic surfactants were employed for selectivity alteration. Both non-ionic surfactants provided good selectivity at concentration 0.2% (v/v) in sodium borate buffer and the separation of six drugs was obtained within 5min. An on-line preconcentration method based on reversed electrode polarity switching was employed for the determination of antihyperglycemic drugs in blood serum after acetonitrile protein precipitation. The limits of detection ranged from 20.8nmolL(-1) for tolbutamide to 6.5nmolL(-1) for glibenclamide, respectively.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19344907     DOI: 10.1016/j.chroma.2009.03.052

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  2 in total

1.  Validated stability-indicating spectrofluorimetric method with enhanced sensitivity for determination of repaglinide in tablets.

Authors:  Rania N El-Shaheny
Journal:  J Fluoresc       Date:  2012-07-01       Impact factor: 2.217

2.  An integrated Taguchi and response surface methodological approach for the optimization of an HPLC method to determine glimepiride in a supersaturatable self-nanoemulsifying formulation.

Authors:  Rajendra Narayan Dash; Habibuddin Mohammed; Touseef Humaira
Journal:  Saudi Pharm J       Date:  2015-03-23       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.